These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 12105241

  • 1. Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathy.
    Donadio JV, Bergstralh EJ, Grande JP, Rademcher DM.
    Nephrol Dial Transplant; 2002 Jul; 17(7):1197-203. PubMed ID: 12105241
    [Abstract] [Full Text] [Related]

  • 2. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.
    Peters HP, Waanders F, Meijer E, van den Brand J, Steenbergen EJ, van Goor H, Wetzels JF.
    Nephrol Dial Transplant; 2011 Nov; 26(11):3581-8. PubMed ID: 21467131
    [Abstract] [Full Text] [Related]

  • 3. IgA nephropathy: prognostic classification of end-stage renal failure. L'Association des Néphrologues de l'Est.
    Frimat L, Briançon S, Hestin D, Aymard B, Renoult E, Huu TC, Kessler M.
    Nephrol Dial Transplant; 1997 Dec; 12(12):2569-75. PubMed ID: 9430853
    [Abstract] [Full Text] [Related]

  • 4. Measures of Urinary Protein and Albumin in the Prediction of Progression of IgA Nephropathy.
    Zhao YF, Zhu L, Liu LJ, Shi SF, Lv JC, Zhang H.
    Clin J Am Soc Nephrol; 2016 Jun 06; 11(6):947-955. PubMed ID: 27026518
    [Abstract] [Full Text] [Related]

  • 5. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
    Zhang X, Shi S, Ouyang Y, Yang M, Shi M, Pan X, Lv J, Wang Z, Ren H, Shen P, Wang W, Zhang H, Xie J, Chen N.
    J Transl Med; 2018 May 03; 16(1):115. PubMed ID: 29724226
    [Abstract] [Full Text] [Related]

  • 6. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study.
    Manno C, Strippoli GF, D'Altri C, Torres D, Rossini M, Schena FP.
    Am J Kidney Dis; 2007 Jun 03; 49(6):763-75. PubMed ID: 17533019
    [Abstract] [Full Text] [Related]

  • 7. Histopathologic features aid in predicting risk for progression of IgA nephropathy.
    Walsh M, Sar A, Lee D, Yilmaz S, Benediktsson H, Manns B, Hemmelgarn B.
    Clin J Am Soc Nephrol; 2010 Mar 03; 5(3):425-30. PubMed ID: 20089495
    [Abstract] [Full Text] [Related]

  • 8. A histologic classification of IgA nephropathy for predicting long-term prognosis: emphasis on end-stage renal disease.
    Kawamura T, Joh K, Okonogi H, Koike K, Utsunomiya Y, Miyazaki Y, Matsushima M, Yoshimura M, Horikoshi S, Suzuki Y, Furusu A, Yasuda T, Shirai S, Shibata T, Endoh M, Hattori M, Katafuchi R, Hashiguchi A, Kimura K, Matsuo S, Tomino Y, Study Group Special IgA Nephropathy.
    J Nephrol; 2013 Mar 03; 26(2):350-7. PubMed ID: 22684645
    [Abstract] [Full Text] [Related]

  • 9. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial.
    Li S, Li JP.
    Trials; 2020 Jan 06; 21(1):31. PubMed ID: 31907076
    [Abstract] [Full Text] [Related]

  • 10. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
    Soleymanian T, Najafi I, Salimi BH, Broomand B.
    Ren Fail; 2011 Jan 06; 33(6):572-7. PubMed ID: 21663387
    [Abstract] [Full Text] [Related]

  • 11. Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: A multi-centre registry study.
    Zhang L, Liu X, Pascoe EM, Badve SV, Boudville NC, Clayton PA, De Zoysa J, Hawley CM, Kanellis J, McDonald SP, Peh CA, Polkinghorne KR, Johnson DW.
    Nephrology (Carlton); 2016 May 06; 21(5):387-96. PubMed ID: 26393772
    [Abstract] [Full Text] [Related]

  • 12. Long-term outcome of IgA nephropathy with minimal change disease: a comparison between patients with and without minimal change disease.
    Li XW, Liang SS, Le WB, Cheng SQ, Zeng CH, Wang JQ, Liu ZH.
    J Nephrol; 2016 Aug 06; 29(4):567-73. PubMed ID: 26537358
    [Abstract] [Full Text] [Related]

  • 13. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population.
    Le W, Liang S, Hu Y, Deng K, Bao H, Zeng C, Liu Z.
    Nephrol Dial Transplant; 2012 Apr 06; 27(4):1479-85. PubMed ID: 21965586
    [Abstract] [Full Text] [Related]

  • 14. Serum immunoglobulin G provides early risk prediction in immunoglobulin A nephropathy.
    Liu D, You J, Liu Y, Tang X, Tan X, Xia M, Wu L, Chen G, He L, Zhu X, Liu H.
    Int Immunopharmacol; 2019 Jan 06; 66():13-18. PubMed ID: 30415190
    [Abstract] [Full Text] [Related]

  • 15. "Point of no return (PNR)" in progressive IgA nephropathy: significance of blood pressure and proteinuria management up to PNR.
    Komatsu H, Fujimoto S, Sato Y, Hara S, Yamada K, Morita S, Eto T.
    J Nephrol; 2005 Jan 06; 18(6):690-5. PubMed ID: 16358226
    [Abstract] [Full Text] [Related]

  • 16. Histological grading of IgA nephropathy predicting renal outcome: revisiting H. S. Lee's glomerular grading system.
    Lee HS, Lee MS, Lee SM, Lee SY, Lee ES, Lee EY, Park SY, Han JS, Kim S, Lee JS.
    Nephrol Dial Transplant; 2005 Feb 06; 20(2):342-8. PubMed ID: 15618239
    [Abstract] [Full Text] [Related]

  • 17. Association of Treatment Effects on Early Change in Urine Protein and Treatment Effects on GFR Slope in IgA Nephropathy: An Individual Participant Meta-analysis.
    Inker LA, Heerspink HJL, Tighiouart H, Chaudhari J, Miao S, Diva U, Mercer A, Appel GB, Donadio JV, Floege J, Li PKT, Maes BD, Locatelli F, Praga M, Schena FP, Levey AS, Greene T.
    Am J Kidney Dis; 2021 Sep 06; 78(3):340-349.e1. PubMed ID: 33775708
    [Abstract] [Full Text] [Related]

  • 18. Early Change in Urine Protein as a Surrogate End Point in Studies of IgA Nephropathy: An Individual-Patient Meta-analysis.
    Inker LA, Mondal H, Greene T, Masaschi T, Locatelli F, Schena FP, Katafuchi R, Appel GB, Maes BD, Li PK, Praga M, Del Vecchio L, Andrulli S, Manno C, Gutierrez E, Mercer A, Carroll KJ, Schmid CH, Levey AS.
    Am J Kidney Dis; 2016 Sep 06; 68(3):392-401. PubMed ID: 27032886
    [Abstract] [Full Text] [Related]

  • 19. [Treatment of IgA nephropathy with chronic renal failure].
    Pozzi C.
    G Ital Nefrol; 2008 Sep 06; 25 Suppl 44():83-7. PubMed ID: 19048591
    [Abstract] [Full Text] [Related]

  • 20. Prediction of ESRD in IgA Nephropathy Patients from an Asian Cohort: A Random Forest Model.
    Liu Y, Zhang Y, Liu D, Tan X, Tang X, Zhang F, Xia M, Chen G, He L, Zhou L, Zhu X, Liu H.
    Kidney Blood Press Res; 2018 Sep 06; 43(6):1852-1864. PubMed ID: 30537719
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.